Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Modafinil is a eugeroic compound that promotes wakefulness by selectively blocking dopamine reuptake transporters and modulating histamine pathways. It enhances cognitive performance and alertness without the jittery effects typical of traditional stimulants.
Reported Benefits (Provisional)
Origin & History
Modafinil is a synthetic eugeroic compound developed to promote wakefulness. It is synthesized through a series of chemical reactions in pharmaceutical laboratories.
Research Narrative (Provisional)
Numerous RCTs and meta-analyses confirm its efficacy in promoting wakefulness and cognitive enhancement, particularly in sleep-deprived individuals.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Synthetic compound with wakefulness-promoting properties. - Acts on the central nervous system to enhance alertness. - Non-addictive with a low potential for abuse.
Reported Mechanism (Provisional)
Modafinil primarily works by blocking dopamine reuptake transporters (DAT), increasing extracellular dopamine concentrations in the nucleus accumbens and prefrontal cortex. It also modulates histamine release in the hypothalamus and affects orexin/hypocretin neurons, which regulate sleep-wake cycles. Additionally, modafinil influences norepinephrine and GABA neurotransmitter systems, contributing to its wake-promoting effects.
Clinical Narrative (Provisional)
Clinical trials involving over 2,000 participants demonstrate modafinil's efficacy for treating narcolepsy, with 200mg daily doses improving wakefulness scores by 40-60% compared to placebo. Studies in healthy individuals show cognitive improvements including 15-20% enhanced working memory and sustained attention. However, most cognitive enhancement research involves small sample sizes (20-50 participants) and short-term administration. Long-term safety data remains limited, with most studies lasting under 12 weeks.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.